Ragon Institute of Mass General, MIT, and Harvard
Benjamin Kellman is an accomplished researcher currently serving as a Research Fellow at the Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital, and Harvard Medical School since April 2022. Prior experience includes roles as a Bioinformatics Scientist at Bionano Genomics, Inc. and Monoceros Biosystems, as well as a PhD Student specializing in network biology at UC San Diego. Educational qualifications include a Doctor of Philosophy in Bioinformatics and Systems Biology from UC San Diego, and a Bachelor of Science in Neurobiology of Brain and Cognitive Science, along with minors in Mathematics and Computer Science, from the University of Rochester. Benjamin also has a background in teaching, having served as a Teaching Assistant and Tutor at the University of Rochester, as well as a Volunteer and Intern involved in bioinformatic projects at the University of Rochester Medical Center.
This person is not in the org chart
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.